Non-invasive Point-of-care Diagnosis Using Machine Learning and Signal Analytics to Transform Early Detection of Heart Disease
IDENTIFY
Non-Invasive Point-of-care Diagnosis Using Machine Learning and Signal Analytics to Transform Early Detection of Heart Disease
1 other identifier
interventional
2,500
1 country
1
Brief Summary
This study is designed as a repository study to collect resting cardiac phase signals and subject meta data from eligible subjects using the Phase Signal Recorder (PSR) prior to coronary angiography. The repository data will be used for the purposes of research, development, optimization and testing of machine-learning algorithms developed by Analytics 4 Life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable coronary-artery-disease
Started Dec 2018
Typical duration for not_applicable coronary-artery-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 10, 2018
CompletedFirst Submitted
Initial submission to the registry
January 1, 2019
CompletedFirst Posted
Study publicly available on registry
March 6, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2022
CompletedJanuary 24, 2022
December 1, 2021
3.6 years
January 1, 2019
January 21, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Phase Signal Recorder Procedure
Resting phase signals will be collected from eligible subjects prior to coronary angiography and paired with angiography results..
7 day
Study Arms (1)
Enrolled Subjects (PSR)
OTHERPatients who meet the study's inclusion and exclusion criteria, including signing the informed consent form, subjects will undergo signal acquisition prior to their scheduled cardiac catheterization on the day of the procedure.
Interventions
The Phase Signal Acquisition (PSAQ) System is a medical device system that is being developed to collect phase signals from patients to support the development and testing of machine learned algorithms. The PSAQ System consists of two components that work together to acquire and transmit the phase signals and patient specific data to a secured, cloud-based repository. The PSAQ System is comprised of: 1) the Phase Signal Recorder (PSR) which is a portable instrument, and 2) the Phase Signal Data Repository (PSDR) which is a cloud based data repository. Data collected during this study will not be used to guide treatment.
Eligibility Criteria
You may qualify if:
- Patients ≥ 18 years old;
- Symptoms suggestive of obstructive CAD;
- Scheduled to undergo cardiac catheterization with coronary angiography;
- Ability to understand the requirements of the study and to provide written informed consent.
You may not qualify if:
- Prior documented history of myocardial infarction (MI);
- Suspected acute myocardial infarction (AMI) at current presentation;
- Prior coronary artery bypass grafting (CABG);
- Prior heart valve replacement;
- Previous sustained or paroxysmal atrial or ventricular arrythmia;
- Infiltrative myocardial disease (amyloid, sarcoid, right ventricular dysplasia);
- Presence of cardiac implantable electronic device (CIED), including implantable cardioverter defibrillator (ICD), pacemaker (PM), implantable loop recorders and other monitors;
- Implantable Neuro-stimulators;
- Congenital Heart Disease;
- Pregnant or breast feeding;
- Currently taking any Type IA, IC or III antiarrhythmics;
- Any history of amiodarone use;
- Clinically significant chest deformity (e.g., pectus excavatum or pectus carinatum);
- Breast implants;
- Neuromuscular Disease if the condition results in tremor or muscle fasciculations.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Atlanta Heart Specialists
Cumming, Georgia, 30041, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
William E Sanders, Jr., MD JD LLM MBA FHRS
Analytics For Life
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 1, 2019
First Posted
March 6, 2019
Study Start
December 10, 2018
Primary Completion
July 1, 2022
Study Completion
July 1, 2022
Last Updated
January 24, 2022
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share